- Home
- TIXT vs AUPH Comparison
TIXT vs AUPH Comparison
Compare TIXT & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIXT
- AUPH
- Stock Information
- Founded
- TIXT 2005
- AUPH 1993
- Country
- TIXT Canada
- AUPH Canada
- Employees
- TIXT N/A
- AUPH N/A
- Industry
- TIXT EDP Services
- AUPH Biotechnology: Pharmaceutical Preparations
- Sector
- TIXT Technology
- AUPH Health Care
- Exchange
- TIXT Nasdaq
- AUPH Nasdaq
- Market Cap
- TIXT 1.0B
- AUPH 1.1B
- IPO Year
- TIXT 2021
- AUPH 1999
- Fundamental
- Price
- TIXT $3.35
- AUPH $7.93
- Analyst Decision
- TIXT Hold
- AUPH Strong Buy
- Analyst Count
- TIXT 10
- AUPH 3
- Target Price
- TIXT $5.70
- AUPH $10.33
- AVG Volume (30 Days)
- TIXT 420.8K
- AUPH 1.0M
- Earning Date
- TIXT 02-13-2025
- AUPH 02-27-2025
- Dividend Yield
- TIXT N/A
- AUPH N/A
- EPS Growth
- TIXT N/A
- AUPH N/A
- EPS
- TIXT N/A
- AUPH N/A
- Revenue
- TIXT $2,658,000,000.00
- AUPH $220,361,000.00
- Revenue This Year
- TIXT $3.46
- AUPH $36.97
- Revenue Next Year
- TIXT $4.58
- AUPH $16.43
- P/E Ratio
- TIXT N/A
- AUPH N/A
- Revenue Growth
- TIXT N/A
- AUPH 38.72
- 52 Week Low
- TIXT $2.83
- AUPH $4.71
- 52 Week High
- TIXT $11.51
- AUPH $10.67
- Technical
- Relative Strength Index (RSI)
- TIXT 38.73
- AUPH 47.47
- Support Level
- TIXT $3.70
- AUPH $7.50
- Resistance Level
- TIXT $4.01
- AUPH $8.12
- Average True Range (ATR)
- TIXT 0.21
- AUPH 0.27
- MACD
- TIXT -0.04
- AUPH 0.02
- Stochastic Oscillator
- TIXT 0.00
- AUPH 53.49
About TIXT TELUS International (Cda) Inc. Subordinate Voting Shares
TELUS International (Cda) Inc is a digital customer experience innovator that designs, builds, and delivers next-generation solutions. Its clients include companies across several verticals, including Tech and Games, eCommerce and FinTech, Banking, Financial Services and Insurance, Communications and Media, and Healthcare. The solutions offered by the company include Digital Experience, Customer Experience, Advisory Services, and Back Office and Automation among other services. Geographically, it derives a majority of its revenue from the European region.
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.